Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2024-01-02 Transaction in Own Shar…
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Transaction in Own Shares Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and its subject is "Bilan semestriel du contrat de liquidité contracté avec GILBERT DUPONT" (Semi-annual statement of the liquidity contract entered into with GILBERT DUPONT). It reports on the status of the liquidity contract (share count and cash balance) as of December 29, 2023, and details the transactions (purchases and sales) executed during the 2nd half of 2023. This type of regular disclosure regarding share repurchase programs or liquidity agreements is a specific corporate action announcement. It is not a full Annual Report (10-K), an Interim Report (IR), or a standard Earnings Release (ER). Since it details transactions in the company's own shares (repurchases/sales under a liquidity agreement), the most appropriate classification is Transaction in Own Shares (POS). It is a direct report of these transactions, not just an announcement that a report is available (which would be RPA/RNS).
2024-01-02 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces a specific corporate event: a software enhancement for the Aeson® artificial heart and the subsequent publication of a "field safety notice." It contains key financial communication elements like contact information for Investor Relations and Press Relations, a disclaimer, and is dated with a specific time (CET). This format strongly indicates an immediate, material disclosure to the market that is not a full periodic report (like 10-K or IR) or a transcript. Since it is a press release announcing a safety/regulatory action and providing immediate context, it fits best as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it were tied to quarterly results, but here it is standalone news. Given the nature of announcing a safety notice and product update via a press release, RNS (Regulatory Filings) is the most appropriate general category for immediate, non-standard disclosures, although it shares characteristics with an ER due to its structure. However, since it is not an earnings announcement, RNS is the best fit as a general regulatory/material disclosure.
2023-12-28 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a significant software improvement for the Aeson® artificial heart, including the publication of a 'field safety notice' ('information de sécurité'). This type of announcement, detailing a product update and regulatory communication, is typically classified as an Earnings Release (ER) if it contains financial highlights, or a Regulatory Filing (RNS) if it's a general regulatory update. However, the core content is an announcement about a product safety/improvement update, which often accompanies or precedes a formal financial report, but is not the full report itself (like 10-K or IR). Since it is a press release announcing a specific operational/safety update and the associated regulatory notice, and it is not a transcript (CT), a formal financial report (IR/10-K), or a dividend notice (DIV), the most appropriate general category for a significant, non-financial-results-focused regulatory announcement that is not covered by other specific codes is Regulatory Filings (RNS). It is not an Earnings Release (ER) as it focuses on product safety, not period financial results. It is not an RPA because it is the content of the announcement, not just an announcement *about* the publication of another document. Given the focus on a safety update requiring a 'field safety notice' publication, it falls under general regulatory communication.
2023-12-28 French
Informations privilégiées / Autres communiqués
AGM Information Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces an "Assemblée générale extraordinaire" (Extraordinary General Meeting) scheduled for January 5, 2024. It details the availability of preparatory documents and the modalities for participation and voting (proxy, correspondence). This announcement is specifically about an upcoming shareholder meeting and the related materials, which strongly aligns with the purpose of an AGM-related announcement or a proxy solicitation document. Since it is an announcement concerning the logistics and materials for a General Meeting, the most appropriate classification is AGM-R (AGM Information), as it directly relates to the meeting itself, even though it's a press release announcing it. It is not a DEF 14A (Remuneration) or DVA (Voting Results), but rather preparatory information for the meeting.
2023-12-15 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and is dated December 11, 2023. It announces a specific operational milestone: the first implantation of the Aeson® artificial heart in a patient with a cardiac tumor, conducted under the EFICAS study. This type of announcement, detailing operational progress, clinical milestones, and key achievements, is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it is a press release announcing significant operational news rather than a full financial report (like 10-K or IR) or a transcript (CT), the most appropriate classification is Earnings Release (ER), as these often contain operational highlights released concurrently with or near financial reporting periods, or Regulatory Filing (RNS) as a general announcement. Given the nature of announcing a specific, positive clinical/operational event, ER is a strong candidate, but since it is not explicitly stating quarterly/periodical financial results (only mentioning the study progress), RNS (Regulatory Filings/General Announcement) is the safest fit for a non-standard, time-sensitive operational update that isn't a formal financial report or a specific management discussion. However, in many databases, major operational/clinical news releases are often grouped with ERs. Given the structure and content (major company news release), I will lean towards ER as it communicates key performance indicators/milestones, even if not strictly financial figures. If it were purely administrative, RNS would be better. Since it's a major operational/clinical achievement announcement, ER fits well as a proxy for key performance updates. The document length is substantial (9723 chars), ruling out RPA based on the 'MENU VS MEAL' rule, as this is the content itself, not just a notice of content.
2023-12-11 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces a specific clinical milestone: the first implant of the Aeson® artificial heart in a patient with a cardiac tumor as part of the EFICAS® study. It includes a date (December 11, 2023), quotes from management and surgeons, and boilerplate 'About CARMAT' and 'Disclaimer' sections typical of a public announcement intended for immediate dissemination to the market and press. This format strongly indicates an Earnings Release (ER) or a general press release announcing significant, non-periodic operational news. Since it is not a full financial report (10-K, IR) or a transcript (CT), and it is a direct announcement of news rather than just a notice of a report being published (RPA), the most appropriate classification for a significant operational/clinical update announced via press release is Earnings Release (ER), as these often contain key operational highlights alongside any financial context, or Regulatory Filing (RNS) if it were purely regulatory. Given the nature of the announcement (a major clinical first), ER is often used for such high-impact news releases, although RNS is a possibility. However, since it is a direct announcement of a clinical event and study progress, and not a standard quarterly financial summary, it fits best as a general announcement. Given the options, and recognizing that this is a major, time-sensitive announcement, it is closest to an Earnings Release (ER) which often encompasses major operational news, or RNS as a general regulatory/market announcement. Since it is not explicitly financial results, RNS is a safer general category for significant, non-standard corporate news, but ER is often used for major operational milestones announced via press release. Given the context of financial reporting databases, major operational news like this is often grouped with ERs or RNS. I will select ER as it conveys the immediate, high-impact nature of the news release, similar to how earnings are released.
2023-12-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.